K

Stellaromics logo

Stellaromics

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$80M


Stellaromics is a Boston-based company that has developed in situ spatial multi-omics technology to accelerate the development of novel drug treatments.

Total Funding

$105M

Headquarters

Boston, USA

Founded

2022

Focus Areas

Spatial Multi-Omics Technology
Drug Development Acceleration
In Situ 3D Profiling
Innovation Investment
Product Development
Commercialization

Investors